RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial
Holubovska et al., Advances in Respiratory Medicine, doi:10.3390/arm92030021
https://c19early.org/holubovska.html